Curia wins 2023 Frost & Sullivan Customer Value Leadership Award
Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative approach and growth strategyALBANY, N.Y.,...
Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative approach and growth strategyALBANY, N.Y.,...
Available nationwide and through most major insurance plans, Equip’s evidence-based treatment is effective among thousands of patientsSAN DIEGO, June 29,...
Distinguished Healthcare Leader Adam Boehler to Join BoardIncoming CEO Parth Mehrotra to Join BoardWill Sherrill Resigns from BoardARLINGTON, Va,, June...
– EVLO common stock expected to begin trading on a split-adjusted basis on June 30, 2023 – CAMBRIDGE, Mass., June 29,...
Submitted NDA for Libervant™ (diazepam) Buccal Film for treatment of seizure clusters in patients between two and five years of...
Webull’s investor community can now access real-time BioSig investor communications and Q&AWestport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig...
Jason Pesterfield, Veteran Med-Tech Executive and Growth Strategist, Named President, and CEO Kirk G. Jacquay, Seasoned Finance & Operations Leader,...
New preclinical data validates that Stealth Editors™ are non-immunogenic, as featured in a poster presentation at the 28th American Peptide...
The study was conducted over two days by a team of global key opinion leaders and with participation of executives...
-- Represents the final step before submission of Investigational New Drug (IND) application to FDA, expected in the second half...
Data indicate that GP-2250 has anti-neoplastic effects in virus-negative MCC cells as evidenced by tumor cell viability, proliferation and migrationGP-2250...
– Patient dosing initiated in LUMUS, a 388 patient Phase 2b clinical trial of ESK-001 for the treatment of SLE...
Data from Phase 1 clinical trial in healthy volunteers show comparable pharmacokinetic, pharmacodynamic and safety profile between U.S. and Japanese...
Highly experienced international Board Leader joins Emergex as the company grows and progresses clinical development of its pipeline of T...
- Grace Breeding’s bio-fertilizer will be marketed under the brand name “Addir™” as a ‘soil improver’– - This represents the...
Announcement Confirms Cingulate on Track with Development and Regulatory MilestonesKANSAS CITY, Kan., June 29, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc....
TORONTO, Ontario and CAMBRIDGE, Massachusetts, June 29, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (NASDAQ: PMNRFXF) (“ProMIS” or...
Company terminated leases of three residential care facilities and redirects cash flow into technology services investments San Antonio, Texas, June...
Potent Antibacterial Efficacy of D-PLEX100 in In-vivo and Phase 2 Clinical Studies against a Wide Range of Bacteria Tested, including...
CALGARY, Alberta, June 29, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...